Jene Jill M. 4

What Happened

• Jene Jill M, a director of Lipocine Inc. (LPCN), was granted 1,764 derivative shares on 2026-06-03. The award is reported at $2.19 per share for a reported total value of $3,863. This transaction is coded as an award/grant (A) — an acquisition of securities as compensation rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-06-03 at $2.19 per share (total reported $3,863).
• Transaction type: Grant/Award of derivative securities (Form 4 code A).
• Vesting: 100% vesting one year from the grant date (vests on or about 2027-06-03) — see footnote F1.
• Shares owned after transaction: Not disclosed on the Form 4.
• Filing timeliness: Report filed 2026-06-04 (the day after the transaction), so the filing appears timely.

Context

• This was a compensation award (derivative) subject to vesting; such grants are commonly part of director compensation and do not necessarily indicate the insider’s market view. Because the award vests in one year, the director does not have immediate unrestricted shares to sell.